Share

|

|

|

Complete remission best for tapering SLE treatment

To prevent systemic lupus erythematosus flare, tapering of corticosteroid or immunosuppressive therapy is best done when patients are in complete remission and have maintained stable disease for at least 6 months, say researchers.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Four distinct Kawasaki disease subgroups identified

Distinct subgroups exist among children with Kawasaki disease, say researchers in findings that provide some clues to the clinical variability of the disease.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Second primary malignancy risk after lymphoma chemotherapy and HSCT determined

Danish researchers have quantified the risk of second primary malignancy in patients with lymphoma who are treated with high-dose chemotherapy and autologous haematopoietic stem-cell transplantation.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Base-edited CAR T-cell therapy shows promise for relapsed, refractory childhood ALL

T-Cells Work to Fight Cancer

Base-edited chimeric antigen receptor T-cell therapy is feasible for the treatment of relapsed or refractory childhood T-cell acute lymphoblastic leukemia, suggests research published in The New England Journal of Medicine.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.